CIK 0001468929 · <br>Emerging growth company
NEXGEL, INC.
Sign in to watch- Ticker
- NXGL
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 264042544
- Phone
- 215 702-8550
- Business address
- 2150 CABOT BLVD WEST,, SUITE B, LANGHORNE, PA, 19047
- Former names
- NEXGEL, INC., AquaMed Technologies, Inc.
Securities
- NXGL Common Stock Nasdaq
- NXGLW Warrant Nasdaq
- 8-K Event Results of operations
- 8-K Event Regulation FD disclosure
- 4 Open-market buy Director bought 2,500 shares at $1.96 ($4,900)
- 4 Open-market buy Director bought 10,500 shares at an average $2.26 ($23,750)
- 4 Open-market buy Director bought 2,980 shares at an average $1.94 ($5,782)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 8-K Event Results of operations · Regulation FD disclosure
- 10-Q Report Quarterly Report
- 4 Open-market buy Director bought 3,558 shares at $2.24 ($7,984)
- 8-K Event Shareholder vote results
- 4 Open-market buy Director bought 10,000 shares at an average $2.49 ($24,850)
- 4 Open-market buy Director bought 3,000 shares at an average $2.41 ($7,220)
- EFFECT Other Notice of Effectiveness
- CORRESP Other Correspondence Between Filers and SEC Staff
- CORRESP Other Correspondence Between Filers and SEC Staff
Page 9 of 17 · 328 filings